Sustainable Strategies for Peptide, Oligonucleotide, and Bioconjugate Production in Pharma and Allied Fields

The use of peptides, oligonucleotides, and bioconjugates as therapeutics has experienced rapid and transformative growth in recent years, delivering substantial benefits to patient health and well-being. However, the production of these types of therapeutics has historically utilized processes that require the extensive use of hazardous reagents, large volumes of solvents, and high process mass intensity. This session will highlight innovative advancements in these fields with an emphasis on the use of green solvents, efficient synthetic processes, and purification strategies that reduce waste. Attendees will learn from researchers in industry and academia about integrating sustainable design principles across drug lifecycle from early-stage synthesis to large-scale manufacturing can support both scientific progress and responsible stewardship in developing next-generation biotherapeutics.

Hanno Erythropel, Ph.D., Yale University

Lars Ratjen

Paul Anastas, Yale University

Peter Licence, The University of Nottingham

Hanno Erythropel, Ph.D., Yale University

Lars Ratjen

Paul Anastas, Yale University

Peter Licence, The University of Nottingham